Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2961181000168119 | Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2961191000168116 | Mitozantrone (Mayne Pharma) (mitozantrone 20 mg / 10 mL) injection, 1 x 10 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | Is a | Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | true | Inferred relationship | Some | ||
| Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | has TPUU | Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | true | Inferred relationship | Some | 1 | |
| Mitozantrone (Mayne Pharma) 20 mg/10 mL injection, 10 mL vial | has TP | Mitozantrone (Mayne Pharma) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR